Webinar
The AV 100 Series: 12 Startups Shaping the Future of Healthcare
Alumni Ventures’ David Shapiro and Mike Peri led The AV 100 Series, spotlighting 12 startups shaping the future of healthcare and revealing what made these companies stand out in today’s healthtech landscape.
See video policy below.
In this session, David and Mike walked through 12 compelling healthtech companies that represented the cutting edge of healthcare innovation. They discussed the key market dynamics, breakthrough technologies, and execution signals that made these startups noteworthy within an increasingly competitive healthcare sector.
The conversation highlighted how venture investors assess innovation across healthtech — from care delivery and digital health to data-driven diagnostics and preventative solutions — and what it took for a startup to break through in a highly regulated, high-impact industry. Attendees gained insight into the critical factors that separated promising healthtech companies from those positioned to become category leaders.
Whether you were a current investor or exploring opportunities in cutting-edge healthcare, this webinar offered valuable perspective on the companies and trends transforming healthcare delivery. Watch the recording to discover 12 startups shaping the future of healthcare and learn how Alumni Ventures evaluates innovation in this essential sector.
Want to access our Healthtech Syndicate startup deals to see, evaluate, and optionally invest? No cost, no commitment.
Key Takeaway
- HomeDiscover 12 innovative healthtech companies addressing critical challenges in modern healthcare
- HomeGain insight into the criteria Alumni Ventures uses to evaluate and select top healthtech startups
- HomeUnderstand the market opportunities, technology differentiation, and execution signals driving healthcare innovation
Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenters
David has over 25 years of experience as an investor, adviser, and board member, with expertise across early- and late-stage venture capital. Before joining Blue Ivy, David was Senior VP of Corporate Development and Business Development for DataXu, a marketer-aligned data and analytics company. Prior to his time at DataXu, he was a Director with the global venture and private equity firm 3i, including board directorships with ten companies. He also worked in the private equity group at GE Asset Management, where he specialized in late-stage venture and growth capital opportunities. David received his BA in History from Yale in 1991 and an MBA from the Tuck School of Business at Dartmouth in 2000.
Mike, an accomplished venture capitalist and operator with over a decade of industry experience, brings a wealth of expertise to Alumni Ventures. Before joining AV as a Partner, he held a Lead Director role at CVS Health Ventures, where he focused on investments in early and growth-stage digital health companies and played a key role in shaping the firm’s portfolio management strategy. Prior to this, Mike served as a Partner at Distributed Ventures, an early-stage fund with a strong thematic emphasis on digital health, insuretech, and fintech sectors. His journey in the industry began with leadership in product and analytics at Yaro Health, a venture-incubated company that achieved a successful acquisition. Throughout his career, Mike has assumed pivotal roles in strategy, early-stage startups, and data science, shaping his comprehensive understanding of the venture landscape. Mike holds a Masters of Science in Applied Data Science from the University of Chicago, along with graduate and undergraduate degrees from DePaul University and the University of Iowa, respectively.